|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.000 USD | -2.44% |
|
-.--% | +46.28% |
| 06-02 | Diaceutics PLC, 2025 Earnings Call, May 26, 2026 | |
| 05-26 | Diaceutics PLC Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -143.14x | 9.51x | 0.49x | 21.82x | 52.41x | -92.78x | -.--% | 59.49B | ||
| 35.29x | 3.84x | 0.46x | 2.7x | 21.36x | 34.29x | 1.25% | 3.94B | ||
| 103.75x | 6.28x | 1.84x | 13.01x | 18.96x | 113.74x | 0.3% | 3.28B | ||
| 39.58x | 14.74x | 56.29x | 12.09x | 27.01x | 31.3x | 1.77% | 1.98B | ||
| -26.56x | 3.84x | 0.46x | - | - | - | 0.1% | 1.3B | ||
| 40.97x | 8.3x | 1.29x | 16.9x | 26.22x | 28.77x | 0.56% | 1.22B | ||
| 15.24x | 4.5x | 0.39x | - | - | - | 0.38% | 1.13B | ||
| 23.42x | 2.03x | 30.08x | 3.68x | 13.25x | 16.37x | 0.7% | 1.07B | ||
| -1.94x | - | 0.24x | 5.11x | 8.35x | 96.52x | -.--% | 527M | ||
| 26.77x | 3.16x | 2.95x | 2.74x | 8.38x | 13.76x | - | 163M | ||
| -60.5x | 4.93x | 0.67x | 1.66x | 12.81x | -42.05x | - | 134M | ||
| 26.11x | 5.88x | -1.36x | 1.04x | 12.12x | 15.56x | -.--% | 72.33M | ||
| Average | 6.58x | 6.09x | 7.82x | 8.07x | 20.09x | 21.55x | 0.51% | 6.19B | |
| Weighted average by Cap. | -106.36x | 8.87x | 2.47x | 19.52x | 46.92x | -67.47x | 0.15% |
- Stock Market
- Stocks
- DXRX Stock
- DIUX.F Stock
- Sector Diaceutics PLC
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















